J-long Group Ltd. (JL) Technical Analysis
$4.66▲5.91%
Market is closed - opens 8 PM, 17 Nov 2025
Insights
- J-long Group is currently in a neutral trading position according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for J-long Group stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, J-long Group stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for J-long Group stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 43.76 | Neutral |
Stochastic | 31.54, 16.86 | Neutral |
Ultimate Oscillator | 32.63 | Neutral |
Stochastic Relative Strength Index | 69.37, 47.27 | Neutral |
Moving Average Convergence Divergence | -0.37, -0.36 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.5 | Sell |
20 | 5.05 | Sell |
50 | 5.62 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.61 | Sell |
20 | 4.9 | Sell |
50 | 5.38 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.61 | Neutral |
20 | 5.36 | Sell |
50 | 5.71 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.36 | Sell |
20 | 4.41 | Sell |
50 | 4.91 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 4.43 | Buy |
20 | 4.25 | Sell |
50 | 4.59 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 4.82 |
Resistance L2 | 4.73 |
Resistance L1 | 4.57 |
Pivot Point | 4.48 |
Support L1 | 4.32 |
Support L2 | 4.23 |
Support L3 | 4.07 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.